SandercockP.BergeE.DennisM.Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Stroke2004; 35:1490–7.
2.
EpifanovY.DodelR.HaackeC.Costs of acute stroke care on regular neurological wards: a comparison with stroke unit setting. Health Policy2007; 81:339–49.
3.
MariniC.RussoT.FelzaniG.Incidence of stroke in young adults: a review. Stroke Res Treat2010; 2011:535672.
4.
HamadA.SokrabT.E.MomeniS.MesraouaB.LingrenA.Stroke in Qatar: a one-year, hospital-based study. J Stroke Cerebrovasc Dis2001; 10:236–41.
5.
GhandehariK.Barriers of thrombolysis therapy in developing countries. Stroke Res Treat2011; 2011:686797.
